成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 100-33-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 100-33-4
Chemical Structure| 100-33-4
Structure of 100-33-4 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 100-33-4 ]

Related Doc. of [ 100-33-4 ]

Alternatived Products of [ 100-33-4 ]
Product Citations

Product Citations

Carla B. Hartman ; Phelelisiwe S. Dube ; Lesetja J. Legoabe , et al. DOI:

Abstract: Several quinoline derivatives incorporating arylnitro and aminochalcone moieties were synthesized and evaluated in vitro against a broad panel of trypanosomatid protozoan parasites responsible for sleeping sickness (Trypanosoma brucei rhodesiense), nagana (Trypanosoma brucei brucei), Chagas disease (Trypanosoma cruzi), and leishmaniasis (Leishmania infantum). Several of the compounds demonstrated significant antiprotozoal activity. Specifically, compounds 2c, 2d, and 4i displayed submicromolar activity against T. b. rhodesiense with half-maximal effective concentration (EC50) values of 0.68, 0.8, and 0.19?μM, respectively, and with a high selectivity relative to human lung fibroblasts and mouse primary macrophages (~100-fold). Compounds 2d and 4i also showed considerable activity against T. b. brucei with EC50 values of 1.4 and 0.4?μM, respectively.

Keywords: anti‐infectives ; arylnitro ; chalcones ; protozoal ; quinoline

Purchased from AmBeed: ; ; ;

Product Details of [ 100-33-4 ]

CAS No. :100-33-4 MDL No. :MFCD00599574
Formula : C19H24N4O2 Boiling Point : -
Linear Structure Formula :- InChI Key :XDRYMKDFEDOLFX-UHFFFAOYSA-N
M.W : 340.42 Pubchem ID :4735
Synonyms :
MP-601205;NSC 9921
Chemical Name :4,4'-(Pentane-1,5-diylbis(oxy))dibenzimidamide

Safety of [ 100-33-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 100-33-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 100-33-4 ]

[ 100-33-4 ] Synthesis Path-Upstream   1~3

  • 1
  • [ 7467-71-2 ]
  • [ 100-33-4 ]
Reference: [1] Journal of Medicinal Chemistry, 1990, vol. 33, # 4, p. 1252 - 1257
[2] Journal of Medicinal Chemistry, 2016, vol. 59, # 2, p. 592 - 608
[3] MedChemComm, 2017, vol. 8, # 2, p. 440 - 444
  • 2
  • [ 111-24-0 ]
  • [ 100-33-4 ]
Reference: [1] Journal of Medicinal Chemistry, 1990, vol. 33, # 4, p. 1252 - 1257
[2] Journal of Medicinal Chemistry, 2016, vol. 59, # 2, p. 592 - 608
  • 3
  • [ 767-00-0 ]
  • [ 100-33-4 ]
Reference: [1] Journal of Medicinal Chemistry, 1990, vol. 33, # 4, p. 1252 - 1257
[2] Journal of Medicinal Chemistry, 2016, vol. 59, # 2, p. 592 - 608
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Similar Product of
[ 100-33-4 ]

Chemical Structure| 50357-45-4

A760549[ 50357-45-4 ]

4,4'-(Pentane-1,5-diylbis(oxy))dibenzimidamide dihydrochloride

Reason: Free-salt

Chemical Structure| 6823-79-6

A448720[ 6823-79-6 ]

4,4'-(Pentane-1,5-diylbis(oxy))dibenzimidamide dimethanesulfonate

Reason: Free-salt

; ;